CL2004000976A1 - Procedimiento de preparacion de preformulaciones farmaceuticas homogeneas que contienen elevada concentracion de esteroides, utiles para la obtencion de preparaciones farmaceuticas solidas o semisolidas de dosis reducida con una concentracion final d - Google Patents

Procedimiento de preparacion de preformulaciones farmaceuticas homogeneas que contienen elevada concentracion de esteroides, utiles para la obtencion de preparaciones farmaceuticas solidas o semisolidas de dosis reducida con una concentracion final d

Info

Publication number
CL2004000976A1
CL2004000976A1 CL200400976A CL2004000976A CL2004000976A1 CL 2004000976 A1 CL2004000976 A1 CL 2004000976A1 CL 200400976 A CL200400976 A CL 200400976A CL 2004000976 A CL2004000976 A CL 2004000976A CL 2004000976 A1 CL2004000976 A1 CL 2004000976A1
Authority
CL
Chile
Prior art keywords
steroid
homogeneous
adjuvant
steroids
procedure
Prior art date
Application number
CL200400976A
Other languages
English (en)
Inventor
Detlef Grawe
Peter Hosel
Peter Mollmann
Carsten Timpe
Michael Dittgen
Klaus Matthey
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CL2004000976A1 publication Critical patent/CL2004000976A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
CL200400976A 1996-12-16 2004-05-07 Procedimiento de preparacion de preformulaciones farmaceuticas homogeneas que contienen elevada concentracion de esteroides, utiles para la obtencion de preparaciones farmaceuticas solidas o semisolidas de dosis reducida con una concentracion final d CL2004000976A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652196A DE19652196A1 (de) 1996-12-16 1996-12-16 Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen

Publications (1)

Publication Number Publication Date
CL2004000976A1 true CL2004000976A1 (es) 2005-01-21

Family

ID=7814809

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400976A CL2004000976A1 (es) 1996-12-16 2004-05-07 Procedimiento de preparacion de preformulaciones farmaceuticas homogeneas que contienen elevada concentracion de esteroides, utiles para la obtencion de preparaciones farmaceuticas solidas o semisolidas de dosis reducida con una concentracion final d

Country Status (13)

Country Link
US (2) US6290931B1 (es)
EP (1) EP0946149B1 (es)
JP (1) JP2001506639A (es)
AT (1) ATE219357T1 (es)
AU (1) AU5748098A (es)
CA (1) CA2275626C (es)
CL (1) CL2004000976A1 (es)
DE (2) DE19652196A1 (es)
DK (1) DK0946149T3 (es)
ES (1) ES2179385T3 (es)
PT (1) PT946149E (es)
RU (1) RU2178694C2 (es)
WO (1) WO1998026762A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
JP2003527310A (ja) * 1999-04-16 2003-09-16 イエナフアルム ゲーエムベーハー ウント ツェーオー． カーゲー エストロゲンを局部的に皮内投与するための医薬品組成物または化粧品組成物
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
IE67345B1 (en) 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
IT1252867B (it) * 1991-12-31 1995-06-28 Gentili Ist Spa Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
WO1993025198A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Ultrafine powder for inhalation and production thereof
US5626871A (en) * 1992-06-12 1997-05-06 Teijin Limited Preparation for intratracheobronchial administration
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen

Also Published As

Publication number Publication date
DK0946149T3 (da) 2002-10-07
CA2275626C (en) 2005-02-15
WO1998026762A1 (de) 1998-06-25
ATE219357T1 (de) 2002-07-15
EP0946149B1 (de) 2002-06-19
US6290931B1 (en) 2001-09-18
AU5748098A (en) 1998-07-15
CA2275626A1 (en) 1998-06-25
RU2178694C2 (ru) 2002-01-27
US20020119103A1 (en) 2002-08-29
DE59707573D1 (de) 2002-07-25
JP2001506639A (ja) 2001-05-22
DE19652196A1 (de) 1998-06-18
PT946149E (pt) 2002-11-29
EP0946149A1 (de) 1999-10-06
ES2179385T3 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
Sjöström et al. Structures of nanoparticles prepared from oil-in-water emulsions
DE3382587D1 (de) Injizierbares langwirkendes mikroteilchen-praeparat zur verabreichung entzuendungshemmender mittel.
PT744941E (pt) Processo para preparar formulacoes farmaceuticas de particulas finas
DK200000266A (da) Farmaceutisk sammensætning indeholdende en opløsning af cyclosporin.
EP0167825A3 (en) Lipid nano pellets as drug carriers for oral administration
DE69905380T2 (de) Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen
BR0317595A (pt) Método e aparelho para produzir partìculas, método para produzir uma mistura de pó seco e composição farmacêutica
KR910009282A (ko) 판크레아틴 제제
MXPA04004730A (es) Composiciones farmaceuticas en forma particulada.
IS5669A (is) Lyfjasamsetning sem mögulegt er að hleypa
MX9207438A (es) Composicion de esferonizacion de celulosa microcristalina.
EA199900201A1 (ru) Фармацевтическая аэрозольная композиция
CA2430318A1 (en) Powder formulation and method for producing the same
CL2004000976A1 (es) Procedimiento de preparacion de preformulaciones farmaceuticas homogeneas que contienen elevada concentracion de esteroides, utiles para la obtencion de preparaciones farmaceuticas solidas o semisolidas de dosis reducida con una concentracion final d
NO932875L (no) Preparater i form av faste partikler som inneholder virksomme substanser, fremgansmaate for fremstilling, samt anvendelse
BR9713258A (pt) Processo para a fabricação de uma preparação pulverosa
Tewa-Tagne et al. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs
EE200000186A (et) Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend
BR0109802A (pt) Preparações farmacêuticas e sua fabricação
JPH11130659A (ja) 水性懸濁医薬品組成物
CA2460649A1 (en) Novel calixarene based dispersible colloidal systems in the form of nanoparticles
PL308838A1 (en) Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations
Pinto et al. A relationship between surface free energy and polarity data and some physical properties of spheroids
WO1999017714A2 (en) Cosmetic compositions containing azelaic acid
WO2005034919B1 (en) Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component